Details of issuance or disposal
Issuance of Series 25 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment
Potential shares: 1,575,200 shares (15,752 Stock Acquisition Rights, with each Stock Acquisition Right entitling the holder to 100 shares)
The lower thin line represents the existing number of shares to which these shares will be added.
¥15,909,520
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 25 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment |
| Number of shares to be issued or disposed of | Potential shares: 1,575,200 shares (15,752 Stock Acquisition Rights, with each Stock Acquisition Right entitling the holder to 100 shares) |
| Issue price and disposal price | ¥1,010 per Stock Acquisition Right |
| Total issue value | ¥15,909,520 |
| Amount of funds to be raised | ¥1,515,814,960 in total, with estimated net proceeds of ¥1,503,029,960 |
| Estimated issuance expenses | ¥12,785,000 (calculated as the difference between the total amount and estimated net proceeds) |
| Payment date | 30 March 2026 |
| Intended allottee | Cantor Fitzgerald Europe: 15,752 Stock Acquisition Rights |
| Exercise price | Initial exercise price: ¥952.2. From 1 April 2026 onward, the exercise price will be adjusted to an amount equivalent to 90% of the closing price on the adjustment reference date, defined as the last trading day of the week preceding the week in which notice of the exercise request is given. The minimum exercise price is ¥685, with no upper limit. |
| Number of Stock Acquisition Rights | Total number issued: 15,752; number of unexercised Stock Acquisition Rights: not disclosed |
| Reason for acquisition without consideration | The Company has disclosed the repurchase of these Stock Acquisition Rights, but the conditions for acquisition without consideration are not disclosed. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the Stock Acquisition Rights issued pursuant to the resolution of the Board of Directors dated 12 March 2026 has been completed.